Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis
British Journal of Pharmacology · 2025
DOI: 10.1111/bph.70218 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Pharmacology, 2025. Verfasst von James Spyrou und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia. Hauptthemen laut MEDLINE: Epilepsy, Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels, Neurons. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 92 Literaturangaben. Gefördert von: Australian Government Research Training Program Scholarship.
Abstract (Originalsprache)
Hyperpolarisation‐activated cyclic nucleotide‐gated (HCN) channels are nonselective voltage‐gated cation channels encoded by four genes ( HCN1‐4 ) that show distinct localisation patterns throughout the central nervous system and body. Among the four isoforms, HCN4 channels are most widely known for their pacemaker activity in cardiac tissue, with HCN4 pathogenic variants being strongly associated with cardiac abnormalities. In the brain, HCN4 channels are predominantly expressed in subcortical regions, where they play roles in regulating brain function including controlling transmitter release, burst firing, and neuronal network oscillatory activity. HCN4 channels also have been proposed as important modulators of general seizure susceptibility. Importantly, accumulating evidence points to HCN4 channel involvement in the aetiology of hyperexcitability in focal cortical dysplasia and tuberous sclerosis. In this review, we have explored the function of HCN4 channels in the brain, focusing on their key roles in modulating both individual neuron and network‐level excitability. More specifically, we have examined the canonical functions of HCN4 channels in regulating rhythmic and oscillatory activity. We have discussed the evidence, from both the clinic and animal modelling, linking aberrant HCN4 channel expression with epilepsy, and evaluated the targeting of HCN4 channels as a potential therapeutic strategy for seizure control.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Florey Institute of Neuroscience and Mental Health, Parkville, Victoria, Australia.
- Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
- Department of Neurosurgery, Yale University School of Medicine, New Haven, Connecticut, USA.
- Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria, Australia.
ORCID-Profile: James Spyrou
Förderung
- Australian Government Research Training Program Scholarship
Zitieren
APA
Spyrou, J., Escobar, I., Bordey, A., & Reid, C. A. (2025). Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis. British Journal of Pharmacology. https://doi.org/10.1111/bph.70218
Vancouver
Spyrou J, Escobar I, Bordey A, Reid CA. Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis. British Journal of Pharmacology. 2025. doi:10.1111/bph.70218
BibTeX
@article{Spyrou2025,
author = {Spyrou, James and Escobar, Iris and Bordey, Angélique and Reid, Christopher A},
title = {Aberrant HCN4 channel expression: Impacts on neuronal excitability and implications for epilepsy pathogenesis},
journal = {British Journal of Pharmacology},
year = {2025},
doi = {10.1111/bph.70218}
}
EUVIMED